REFERENCES
- Adler E. P., Lemken C. A., Katchen N. S., Kurt R. A. A dual role for tumor-derived chemokine RANTES (CCL5). Immunol. Lett 2003; 90: 187–194, [INFOTRIEVE], [CSA]
- Akasaki Y., Liu G., Chung N. H., Ehtesham M., Black K. L., Yu J. S. Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma. J. Immunol 2004; 173: 4352–4359, [INFOTRIEVE], [CSA]
- Almand B., Resser J. R., Lindman B., Nadaf S., Clark J. I., Kwon E. D., Carbone D. P., Gabrilovich D. I. Clinical significance of defective dendritic cell differentiation in cancer. Clin. Cancer Res 2000; 6: 1755–1766, [INFOTRIEVE], [CSA]
- Armant M., Avice M. N., Hermann P., Rubio M., Kiniwa M., Delespesse G., Sarfati M. CD47 ligation selectively downregulates human interleukin 12 production. J. Exp. Med 1999; 190: 1175–1182, [INFOTRIEVE], [CSA], [CROSSREF]
- Bajou K., Noel A., Gerard R. D., Masson V., Brunner N., Holst-Hansen C., Skobe M., Fusenig N. E., Carmeliet P., Collen D., Foidart J. M. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med 1998; 4: 923–928, [INFOTRIEVE], [CSA], [CROSSREF]
- Balkwill F. Tumor necrosis factor or tumor promoting factor?. Cytokine Growth Factor Rev 2002; 13: 135–141, [INFOTRIEVE], [CSA], [CROSSREF]
- Balkwill F. Cancer and the chemokine network. Nat. Rev. Cancer 2004; 4: 540–550, [INFOTRIEVE], [CSA], [CROSSREF]
- Balkwill F., Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001; 357: 539–545, [INFOTRIEVE], [CSA], [CROSSREF]
- Barcellos-Hoff M. H., Ravani S. A. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 2000; 60: 1254–1260, [INFOTRIEVE], [CSA]
- Bell D., Chomarat P., Broyles D., Netto G., Harb G. M., Lebecque S., Valladeau J., Davoust J., Palucka K. A., Banchereau J. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J. Exp. Med 1999; 190: 1417–1426, [INFOTRIEVE], [CSA], [CROSSREF]
- Bellocq A., Antoine M., Flahault A., Philippe C., Crestani B., Bernaudin J. F., Mayaud C., Milleron B., Baud L., Cadranel J. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am. J. Pathol 1998; 152: 83–92, [INFOTRIEVE], [CSA]
- Bellone G., Smirne C., Mauri F. A., Tonel E., Carbone A., Buffolino A., Dughera L., Robecchi A., Pirisi M., Emanuelli G. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol Immunother 2006; 55: 684–698, [INFOTRIEVE], [CSA], [CROSSREF]
- Ben-Baruch A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 2003; 5: 31–36, [INFOTRIEVE], [CSA], [CROSSREF]
- Ben-Baruch A. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Semin Cancer Biol 2006; 16: 38–52, [INFOTRIEVE], [CSA], [CROSSREF]
- Bhowmick N. A., Neilson E. G., Moses H. L. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432: 332–337, [INFOTRIEVE], [CSA], [CROSSREF]
- Bingle L., Brown N. J., Lewis C. E. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002; 196: 254–65, [INFOTRIEVE], [CSA], [CROSSREF]
- Biswas S. K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., Bottazzi B., Doni A., Bronte V., Pasqualini F., Vago L., Nebuloni M., Mantovani A., Sica A. A distinct and unique transcriptional programme expressed by tumor-associated macrophages: defective NF-{kappa}B and enhanced IRF-3/STAT1 activation. Blood 2006; 107: 2112–2122, [INFOTRIEVE], [CSA], [CROSSREF]
- Bluestone J. A., Abbas A. K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol 2003; 3: 253–257, [INFOTRIEVE], [CSA], [CROSSREF]
- Bogdan C. Nitric oxide and the immune response. Nat. Immunol 2001; 2: 907–916, [INFOTRIEVE], [CSA], [CROSSREF]
- Bronte V., Chappell D. B., Apolloni E., Cabrelle A., Wang M., Hwu P., Restifo N. P. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J. Immunol 1999; 162: 5728–5737, [INFOTRIEVE], [CSA]
- Bronte V., Kasic T., Gri G., Gallana K., Borsellino G., Marigo I., Battistini L., Iafrate M., Prayer-Galetti T., Pagano F., Viola A. Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers. J. Exp. Med 2005; 201: 1257–1268, [INFOTRIEVE], [CSA], [CROSSREF]
- Bronte V., Wang M., Overwijk W. W., Surman D. R., Pericle F., Rosenberg S. A., Restifo N. P. Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells. J. Immunol 1998; 161: 5313–5320, [INFOTRIEVE], [CSA]
- Bronte V., Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat. Rev. Immunol 2005; 5: 641–654, [INFOTRIEVE], [CSA], [CROSSREF]
- Cabral G. A. Lipids as bioeffectors in the immune system. Life Sci 2005; 77: 1699–1710, [INFOTRIEVE], [CSA], [CROSSREF]
- Carson-Walter E. B., Watkins D. N., Nanda A., Vogelstein B., Kinzler K. W., St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001; 61: 6649–6655, [INFOTRIEVE], [CSA]
- Caruso R. A., Bellocco R., Pagano M., Bertoli G., Rigoli L., Inferrera C. Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod. Pathol 2002; 15: 831–837, [INFOTRIEVE], [CSA], [CROSSREF]
- Cederbaum S. D., Yu H., Grody W. W., Kern R. M., Yoo P., Iyer R. K. Arginases I and II: do their functions overlap?. Mol. Genet. Metab 2004; 81(Suppl 1)S38–44, [INFOTRIEVE], [CSA], [CROSSREF]
- Chaux P., Favre N., Martin M., Martin F. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 1997; 72: 619–624, [INFOTRIEVE], [CSA], [CROSSREF]
- Chomarat P., Banchereau J., Davoust J., Palucka A. K. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat. Immunol 2000; 1: 510–514, [INFOTRIEVE], [CSA], [CROSSREF]
- Colleluori D. M., Ash D. E. Classical and slow-binding inhibitors of human type II arginase. Biochemistry 2001; 40: 9356–9362, [INFOTRIEVE], [CSA], [CROSSREF]
- Coussens L. M., Werb Z. Inflammatory cells and cancer: think different!. J. Exp. Med 2001; 193: F23–26, [INFOTRIEVE], [CSA], [CROSSREF]
- Coussens L. M., Werb Z. Inflammation and cancer. Nature 2002; 420: 860–867, [INFOTRIEVE], [CSA], [CROSSREF]
- Cunha G. R., Hayward S. W., Wang Y. Z., Ricke W. A. Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 2003; 107: 1–10, [INFOTRIEVE], [CSA], [CROSSREF]
- Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M. L., Knutson K. L., Chen L., Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med 2004; 10: 942–949, [INFOTRIEVE], [CSA], [CROSSREF]
- Davel L. E., Jasnis M. A., de la Torre E., Gotoh T., Diament M., Magenta G., Sacerdote de Lustig E., Sales M. E. Arginine metabolic pathways involved in the modulation of tumor-induced angiogenesis by macrophages. FEBS Lett 2002; 532: 216–220, [INFOTRIEVE], [CSA], [CROSSREF]
- De Palma M., Venneri M. A., Galli R., Sergi L. S., Politi L. S., Sampaolesi M., Naldini L. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8: 211–226, [INFOTRIEVE], [CSA], [CROSSREF]
- De Palma M., Venneri M. A., Roca C., Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med 2003; 9: 789–795, [INFOTRIEVE], [CSA], [CROSSREF]
- De Santo C., Serafini P., Marigo I., Dolcetti L., Bolla M., Del Soldato P., Melani C., Guiducci C., Colombo M. P., Iezzi M., Musiani P., Zanovello P., Bronte V. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination. Proc. Natl. Acad. Sci 2005; 102: 4185–4190, [INFOTRIEVE], [CSA], [CROSSREF]
- de Visser K. E., Korets L. V., Coussens L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7: 411–23, [INFOTRIEVE], [CSA], [CROSSREF]
- De Vita F., Orditura M., Galizia G., Romano C., Lieto E., Iodice P., Tuccillo C., Catalano G. Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol. Rep 2000; 7: 357–361, [INFOTRIEVE], [CSA]
- De Wever O., Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol 2003; 200: 429–447, [INFOTRIEVE], [CSA], [CROSSREF]
- Demeure C. E., Tanaka H., Mateo V., Rubio M., Delespesse G., Sarfati M. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol 2000; 164: 2193–2199, [INFOTRIEVE], [CSA]
- Diehl S., Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol. Immunol 2002; 39: 531–536, [INFOTRIEVE], [CSA], [CROSSREF]
- Dingemans K. P., Zeeman-Boeschoten I. M., Keep R. F., Das P. K. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int. J. Cancer 1993; 54: 1010–1016, [INFOTRIEVE], [CSA]
- Dong H., Strome S. E., Salomao D. R., Tamura H., Hirano F., Flies D. B., Roche P. C., Lu J., Zhu G., Tamada K., Lennon V. A., Celis E., Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med 2002; 8: 793–800, [INFOTRIEVE], [CSA]
- Dua R. S., Gui G. P., Isacke C. M. Endothelial adhesion molecules in breast cancer invasion into the vascular and lymphatic systems. Eur. J. Surg. Oncol 2005; 31: 824–832, [INFOTRIEVE], [CSA], [CROSSREF]
- Dunn G. P., Bruce A. T., Ikeda H., Old L. J., Schreiber R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol 2002; 3: 991–998, [INFOTRIEVE], [CSA], [CROSSREF]
- Dvorak H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med 1986; 315: 1650–1659, [INFOTRIEVE], [CSA]
- Enk A. H., Jonuleit H., Saloga J., Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 1997; 73: 309–316, [INFOTRIEVE], [CSA], [CROSSREF]
- Fallarino F., Grohmann U., Hwang K. W., Orabona C., Vacca C., Bianchi R., Belladonna M. L., Fioretti M. C., Alegre M. L., Puccetti P. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol 2003; 4: 1206–12, [INFOTRIEVE], [CSA], [CROSSREF]
- Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res 2000; 55: 15–35, discussion 35–36[INFOTRIEVE], [CSA]
- Fiorucci S., Santucci L., Gresele P., Faccino R. M., Del Soldato P., Morelli A. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology 2003; 124: 600–607, [INFOTRIEVE], [CSA]
- Framson P. E., Sage E. H. SPARC and tumor growth: where the seed meets the soil?. J. Cell Biochem 2004; 92: 679–690, [INFOTRIEVE], [CSA], [CROSSREF]
- Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol 2004; 4: 941–952, [INFOTRIEVE], [CSA], [CROSSREF]
- Gabrilovich D., Ishida T., Oyama T., Ran S., Kravtsov V., Nadaf S., Carbone D. P. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 1998; 92: 4150–66, [INFOTRIEVE], [CSA]
- Gabrilovich D. I., Chen H. L., Girgis K. R., Cunningham H. T., Meny G. M., Nadaf S., Kavanaugh D., Carbone D. P. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat. Med 1996; 2: 1096–1103, [INFOTRIEVE], [CSA], [CROSSREF]
- Gabrilovich D. I., Corak J., Ciernik I. F., Kavanaugh D., Carbone D. P. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin. Cancer Res 1997; 3: 483–490, [INFOTRIEVE], [CSA]
- Gasparini G., Longo R., Sarmiento R., Morabito A. Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?. Lancet Oncol 2003; 4: 605–615, [INFOTRIEVE], [CSA], [CROSSREF]
- Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol 2003; 3: 23–35, [INFOTRIEVE], [CSA], [CROSSREF]
- Grimm C., Six L., Tomovski C., Speiser P., Joura E., Zeillinger R., Sliutz G., Reinthaller A., Hefler L. A. A common interleukin-6 promoter polymorphism in patients with vulvar cancer. J. Soc. Gynecol. Investig 2005; 12: 617–620, [INFOTRIEVE], [CSA], [CROSSREF]
- Grohmann U., Fallarino F., Puccetti P. Tolerance, DCs and tryptophan: much ado about IDO. Trends Immunol 2003; 24: 242–248, [INFOTRIEVE], [CSA], [CROSSREF]
- Grossman W. J., Verbsky J. W., Barchet W., Colonna M., Atkinson J. P., Ley T. J. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004; 21: 589–601, [INFOTRIEVE], [CSA], [CROSSREF]
- Gualde N., Harizi H. Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol. Cell. Biol 2004; 82: 353–360, [INFOTRIEVE], [CSA], [CROSSREF]
- Haghnegahdar H., Du J., Wang D., Strieter R. M., Burdick M. D., Nanney L. B., Cardwell N., Luan J., Shattuck-Brandt R., Richmond A. The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol 2000; 67: 53–62, [INFOTRIEVE], [CSA]
- Hamada I., Kato M., Yamasaki T., Iwabuchi K., Watanabe T., Yamada T., Itoyama S., Ito H., Okada K. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res 2002; 22: 4281–4284, [INFOTRIEVE], [CSA]
- Hildbrand P., Cirulli V., Prinsen R. C., Smith K. A., Torbett B. E., Salomon D. R., Crisa L. The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors. Blood 2004; 104: 2010–2019, [INFOTRIEVE], [CSA], [CROSSREF]
- Hildenbrand R., Dilger I., Horlin A., Stutte H. J. Urokinase and macrophages in tumour angiogenesis. Br. J. Cancer 1995; 72: 818–823, [INFOTRIEVE], [CSA]
- Hoffmann T. K., Muller-Berghaus J., Ferris R. L., Johnson J. T., Storkus W. J., Whiteside T. L. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck. Clin. Cancer Res 2002; 8: 1787–1793, [INFOTRIEVE], [CSA]
- Hsieh C. S., Liang Y., Tyznik A. J., Self S. G., Liggitt D., Rudensky A. Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2004; 21: 267–277, [INFOTRIEVE], [CSA], [CROSSREF]
- Jones P. L., Jones F. S. Tenascin-C in development and disease: gene regulation and cell function. Matrix Biol 2000; 19: 581–596, [INFOTRIEVE], [CSA], [CROSSREF]
- Kaminska B., Wesolowska A., Danilkiewicz M. TGF beta signalling and its role in tumour pathogenesis. Acta Biochim. Pol 2005; 52: 329–337, [INFOTRIEVE], [CSA]
- Kammertoens T., Schuler T., Blankenstein T. Immunotherapy: target the stroma to hit the tumor. Trends Mol. Med 2005; 11: 225–231, [INFOTRIEVE], [CSA], [CROSSREF]
- Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., Shimizu J., Nomura T., Chiba T., Sakaguchi S. Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3 + CD25 + CD4+ regulatory T cells. J. Exp. Med 2005; 202: 885–891, [INFOTRIEVE], [CSA], [CROSSREF]
- Kulbe H., Hagemann T., Szlosarek P. W., Balkwill F. R., Wilson J. L. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res 2005; 65: 10355–10362, [INFOTRIEVE], [CSA], [CROSSREF]
- Kusmartsev S., Gabrilovich D. I. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol 2005; 174: 4880–4891, [INFOTRIEVE], [CSA]
- Kusmartsev S., Gabrilovich D. I. Role Of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol. Immunother 2006; 55: 237–245, [INFOTRIEVE], [CSA], [CROSSREF]
- Kusmartsev S., Nefedova Y., Yoder D., Gabrilovich D. I. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J. Immunol 2004; 172: 989–999, [INFOTRIEVE], [CSA]
- Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., Ono M. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004; 18: 300–310, [INFOTRIEVE], [CSA], [CROSSREF]
- Leek R. D., Hunt N. C., Landers R. J., Lewis C. E., Royds J. A., Harris A. L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol 2000; 190: 430–436, [INFOTRIEVE], [CSA], [CROSSREF]
- Lejeune F. J., Ruegg C., Lienard D. Clinical applications of TNF-alpha in cancer. Curr. Opin. Immunol 1998; 10: 573–580, [INFOTRIEVE], [CSA], [CROSSREF]
- Lewis J. S., Landers R. J., Underwood J. C., Harris A. L., Lewis C. E. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas. J. Pathol 2000; 192: 150–158, [INFOTRIEVE], [CSA], [CROSSREF]
- Lieubeau B., Heymann M. F., Henry F., Barbieux I., Meflah K., Gregoire M. Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development. Int. J. Cancer 1999; 81: 629–636, [INFOTRIEVE], [CSA], [CROSSREF]
- Lin E. Y., Pollard J. W. Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 2004; 90: 2053–2058, [INFOTRIEVE], [CSA], [CROSSREF]
- Liotta L. A., Kohn E. C. The microenvironment of the tumour-host interface. Nature 2001; 411: 375–379, [INFOTRIEVE], [CSA], [CROSSREF]
- Mackie E. J. Molecules in focus: tenascin-C. Int J Biochem Cell Biol 1997; 29: 1133–1137, [INFOTRIEVE], [CSA], [CROSSREF]
- Maeda H., Shiraishi A. TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol 1996; 156: 73–78, [INFOTRIEVE], [CSA]
- Maisonpierre P. C., Suri C., Jones P. F., Bartunkova S., Wiegand S. J., Radziejewski C., Compton D., McClain J., Aldrich T. H., Papadopoulos N., Daly T. J., Davis S., Sato T. N., Yancopoulos G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55–60, [INFOTRIEVE], [CSA], [CROSSREF]
- Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677–686, [INFOTRIEVE], [CSA], [CROSSREF]
- Mantovani A., Sozzani S., Locati M., Allavena P., Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23: 549–555, [INFOTRIEVE], [CSA], [CROSSREF]
- Marrogi A. J., Munshi A., Merogi A. J., Ohadike Y., El-Habashi A., Marrogi O. L., Freeman S. M. Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int. J. Cancer 1997; 74: 492–501, [INFOTRIEVE], [CSA], [CROSSREF]
- Melani C., Chiodoni C., Forni G., Colombo M. P. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood 2003; 102: 2138–2145, [INFOTRIEVE], [CSA], [CROSSREF]
- Mellor A. L., Munn D. H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol 2004; 4: 762–774, [INFOTRIEVE], [CSA], [CROSSREF]
- Menetrier-Caux C., Montmain G., Dieu M. C., Bain C., Favrot M. C., Caux C., Blay J. Y. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998; 92: 4778–4791, [INFOTRIEVE], [CSA]
- Mocellin S., Mandruzzato S., Bronte V., Lise M., Nitti D. Part I: Vaccines for solid tumours. Lancet Oncol 2004; 5: 681–689, [INFOTRIEVE], [CSA], [CROSSREF]
- Mueller M. M., Fusenig N. E. Friends or foes—bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004; 4: 839–849, [INFOTRIEVE], [CSA], [CROSSREF]
- Mueller M. M., Herold-Mende C. C., Riede D., Lange M., Steiner H. H., Fusenig N. E. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am. J. Pathol 1999; 155: 1557–1567, [INFOTRIEVE], [CSA]
- Mueller M. M., Peter W., Mappes M., Huelsen A., Steinbauer H., Boukamp P., Vaccariello M., Garlick J., Fusenig N. E. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am. J. Pathol 2001; 159: 1567–1579, [INFOTRIEVE], [CSA]
- Muller A. J., DuHadaway J. B., Donover P. S., Sutanto-Ward E., Prendergast G. C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med 2005; 11: 312–319, [INFOTRIEVE], [CSA], [CROSSREF]
- Muller G., Muller A., Tuting T., Steinbrink K., Saloga J., Szalma C., Knop J., Enk A. H. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol 2002; 119: 836–841, [INFOTRIEVE], [CSA], [CROSSREF]
- Munn D. H., Sharma M. D., Hou D., Baban B., Lee J. R., Antonia S. J., Messina J. L., Chandler P., Koni P. A., Mellor A. L. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 2004; 114: 280–90, [INFOTRIEVE], [CSA], [CROSSREF]
- Munn D. H., Zhou M., Attwood J. T., Bondarev I., Conway S. J., Marshall B., Brown C., Mellor A. L. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191–3, [INFOTRIEVE], [CSA], [CROSSREF]
- Naito Y., Saito K., Shiiba K., Ohuchi A., Saigenji K., Nagura H., Ohtani H. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491–4, [INFOTRIEVE], [CSA]
- Nakano O., Sato M., Naito Y., Suzuki K., Orikasa S., Aizawa M., Suzuki Y., Shintaku I., Nagura H., Ohtani H. Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res 2001; 61: 5132–6, [INFOTRIEVE], [CSA]
- Nakao S., Kuwano T., Tsutsumi-Miyahara C., Ueda S., Kimura Y. N., Hamano S., Sonoda K. H., Saijo Y., Nukiwa T., Strieter R. M., Ishibashi T., Kuwano M., Ono M. Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1beta-induced neovascularization and tumor growth. J Clin Invest 2005; 115: 2979–91, [INFOTRIEVE], [CSA], [CROSSREF]
- Obermueller E., Vosseler S., Fusenig N. E., Mueller M. M. Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Res 2004; 64: 7801–12, [INFOTRIEVE], [CSA], [CROSSREF]
- Ochsenbein A. F., Klenerman P., Karrer U., Ludewig B., Pericin M., Hengartner H., Zinkernagel R. M. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 1999; 96: 2233–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Ochsenbein A. F., Sierro S., Odermatt B., Pericin M., Karrer U., Hermans J., Hemmi S., Hengartner H., Zinkernagel R. M. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction. Nature 2001; 411: 1058–64, [INFOTRIEVE], [CSA], [CROSSREF]
- Ohuchida K., Mizumoto K., Murakami M., Qian L. W., Sato N., Nagai E., Matsumoto K., Nakamura T., Tanaka M. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004; 64: 3215–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Orabona C., Tomasello E., Fallarino F., Bianchi R., Volpi C., Bellocchio S., Romani L., Fioretti M. C., Vivier E., Puccetti P., Grohmann U. Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12. Eur J Immunol 2005; 35: 3111–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Orlandini M., Oliviero S. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J Biol Chem 2001; 276: 6576–81, [INFOTRIEVE], [CSA], [CROSSREF]
- Otsuji M., Kimura Y., Aoe T., Okamoto Y., Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci U S A 1996; 93: 13119–24, [INFOTRIEVE], [CSA], [CROSSREF]
- Oyama T., Ran S., Ishida T., Nadaf S., Kerr L., Carbone D. P., Gabrilovich D. I. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. J Immunol 1998; 160: 1224–32, [INFOTRIEVE], [CSA]
- Park S. J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 2004; 173: 3844–54, [INFOTRIEVE], [CSA]
- Partridge M., Chantry D., Turner M., Feldmann M. Production of interleukin-1 and interleukin-6 by human keratinocytes and squamous cell carcinoma cell lines. J Invest Dermatol 1991; 96: 771–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25+ T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Paust S., Lu L., McCarty N., Cantor H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc Natl Acad Sci U S A 2004; 101: 10398–403, [INFOTRIEVE], [CSA], [CROSSREF]
- Pollard J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4: 71–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Rochet N., Dubousset J., Mazeau C., Zanghellini E., Farges M. F., de Novion H. S., Chompret A., Delpech B., Cattan N., Frenay M., Gioanni J. Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72). Int J Cancer 1999; 82: 282–5, [INFOTRIEVE], [CSA], [CROSSREF]
- Rodriguez P. C., Quiceno D. G., Zabaleta J., Ortiz B., Zea A. H., Piazuelo M. B., Delgado A., Correa P., Brayer J., Sotomayor E. M., Antonia S., Ochoa J. B., Ochoa A. C. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839–49, [INFOTRIEVE], [CSA], [CROSSREF]
- Sangaletti S., Stoppacciaro A., Guiducci C., Torrisi M. R., Colombo M. P. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma. J Exp Med 2003; 198: 1475–85, [INFOTRIEVE], [CSA], [CROSSREF]
- Schaider H., Oka M., Bogenrieder T., Nesbit M., Satyamoorthy K., Berking C., Matsushima K., Herlyn M. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer 2003; 103: 335–43, [INFOTRIEVE], [CSA], [CROSSREF]
- Schumacher K., Haensch W., Roefzaad C., Schlag P. M. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 2001; 61: 3932–6, [INFOTRIEVE], [CSA]
- Sebollela A., Cagliari T. C., Limaverde G. S., Chapeaurouge A., Sorgine M. H., Coelho-Sampaio T., Ramos C. H., Ferreira S. T. Heparin-binding sites in granulocyte-macrophage colony-stimulating factor. Localization and regulation by histidine ionization. J Biol Chem 2005; 280: 31949–56, [INFOTRIEVE], [CSA], [CROSSREF]
- Serafini P., Borrello I., Bronte V. Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol 2005, [CSA]
- Shankaran V., Ikeda H., Bruce A. T., White J. M., Swanson P. E., Old L. J., Schreiber R. D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001; 410: 1107–11, [INFOTRIEVE], [CSA], [CROSSREF]
- Shevach E. M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389–400, [INFOTRIEVE], [CSA]
- Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25 + CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999; 163: 5211–8, [INFOTRIEVE], [CSA]
- Sombroek C. C., Stam A. G., Masterson A. J., Lougheed S. M., Schakel M. J., Meijer C. J., Pinedo H. M., van den Eertwegh A. J., Scheper R. J., de Gruijl T. D. Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation. J Immunol 2002; 168: 4333–43, [INFOTRIEVE], [CSA]
- Spiotto M. T., Rowley D. A., Schreiber H. Bystander elimination of antigen loss variants in established tumors. Nat Med 2004; 10: 294–8, [INFOTRIEVE], [CSA], [CROSSREF]
- St Croix B., Rago C., Velculescu V., Traverso G., Romans K. E., Montgomery E., Lal A., Riggins G. J., Lengauer C., Vogelstein B., Kinzler K. W. Genes expressed in human tumor endothelium. Science 2000; 289: 1197–202, [INFOTRIEVE], [CSA], [CROSSREF]
- Steinbrink K., Graulich E., Kubsch S., Knop J., Enk A. H. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002; 99: 2468–76, [INFOTRIEVE], [CSA], [CROSSREF]
- Tanaka T., Bai Z., Srinoulprasert Y., Yang B. G., Hayasaka H., Miyasaka M. Chemokines in tumor progression and metastasis. Cancer Sci 2005; 96: 317–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Terness P., Chuang J. J., Bauer T., Jiga L., Opelz G. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?. Blood 2005; 105: 2480–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Ulrich C. M., Bigler J., Potter J. D. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nature Review Cancer 2006; 6: 130–140, [CSA], [CROSSREF]
- Uotila P. The role of cyclic AMP and oxygen intermediates in the inhibition of cellular immunity in cancer. Cancer Immunol Immunother 1996; 43: 1–9, [INFOTRIEVE], [CSA]
- Uyttenhove C., Pilotte L., Theate I., Stroobant V., Colau D., Parmentier N., Boon T., Van den Eynde B. J. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003; 9: 1269–74, [INFOTRIEVE], [CSA], [CROSSREF]
- Valkovic T., Lucin K., Krstulja M., Dobi-Babic R., Jonjic N. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer. Pathol Res Pract 1998; 194: 335–40, [INFOTRIEVE], [CSA]
- Vallance P., Leiper J. Blocking NO synthesis: how, where and why?. Nat Rev Drug Discov 2002; 1: 939–50, [INFOTRIEVE], [CSA], [CROSSREF]
- Voronov E., Shouval D. S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., Dinarello C. A., Apte R. N. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci U S A 2003; 100: 2645–50, [INFOTRIEVE], [CSA], [CROSSREF]
- Wang H. Y., Lee D. A., Peng G., Guo Z., Li Y., Kiniwa Y., Shevach E. M., Wang R. F. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004; 20: 107–18, [INFOTRIEVE], [CSA], [CROSSREF]
- Williams C. S., Mann M., DuBois R. N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908–16, [INFOTRIEVE], [CSA], [CROSSREF]
- Wingender G., Garbi N., Schumak B., Jungerkes F., Endl E., von Bubnoff D., Steitz J., Striegler J., Moldenhauer G., Tuting T., Heit A., Huster K. M., Takikawa O., Akira S., Busch D. H., Wagner H., Hammerling G. J., Knolle P. A., Limmer A. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol 2006; 36: 12–20, [INFOTRIEVE], [CSA], [CROSSREF]
- Wislez M., Fleury-Feith J., Rabbe N., Moreau J., Cesari D., Milleron B., Mayaud C., Antoine M., Soler P., Cadranel J. Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma. Am J Pathol 2001; 159: 1423–33, [INFOTRIEVE], [CSA]
- Yang L., DeBusk L. M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., Matrisian L. M. D., Carbone P., Lin P. C. Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004; 6: 409–21, [INFOTRIEVE], [CSA], [CROSSREF]
- Yu P., Lee Y., Liu W., Chin R. K., Wang J., Wang Y., Schietinger A., Philip M., Schreiber H., Fu Y. X. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 2004; 5: 141–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Yu P., Lee Y., Liu W., Krausz T., Chong A., Schreiber H., Fu Y. X. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med 2005; 201: 779–91, [INFOTRIEVE], [CSA], [CROSSREF]
- Yuan A., Yu C. J., Shun C. T., Luh K. T., Kuo S. H., Lee Y. C., Yang P. C. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients. Int J Cancer 2005; 115: 545–55, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang L., Conejo-Garcia J. R., Katsaros D., Gimotty P. A., Massobrio M., Regnani G., Makrigiannakis A., Gray H., Schlienger K., Liebman M. N., Rubin S. C., Coukos G. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203–13, [INFOTRIEVE], [CSA], [CROSSREF]
- Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005; 5: 263–74, [INFOTRIEVE], [CSA], [CROSSREF]